CClinicalTrials.gg
CompletedNCT04006613Updated Jul 8, 2025

Effects of a Circuit Training on Balance in Persons With Multiple Sclerosis

An interventional study of Circuit Training and Usual Care in Multiple Sclerosis, sponsored by Fondazione Don Carlo Gnocchi Onlus. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by Fondazione Don Carlo Gnocchi Onlus · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Feb 2019, registered May 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of the study is to evaluate the effects of a circuit training rehabilitation program on the perceived impact of fatigue in daily life situations and on gait and balance. Half of the participants will follow the circuit training program, while the other half will follow usual care rehabilitation programs.

Read the detailed description

Approximately 80% of Persons with Multiple Sclerosis rates fatigue among the three most disabling symptoms. Aerobic, balance and strength training have already been proved effective in rehabilitation, especially for Persons with Multiple Sclerosis. Fifty-two Persons with Multiple Sclerosis will be randomly allocated to an experimental group or to a control group following usual care rehabilitation programs. Experimental group will follow a circuit training rehabilitation program which combines high intensity aerobic training with balance and strength training. The study aims to verify the effects of the circuit training program on fatigue and on balance in different contexts with respect to usual care rehabilitation programs and to investigate effects of rehabilitation on immunological markers.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • Fatigue
  • Balance
  • Aerobic training
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 52 is close to the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Fondazione Don Carlo Gnocchi Onlus is the lead sponsor of 146 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Definite diagnosis of Multiple Sclerosis (Polman criteria);
  • No relapses in the previous three months;
  • Expanded Disability Status Scale \< 6,5;
  • Able to walk 20 meter with or without an assistive device;
  • Able to stand for 30 second without aid;
  • MiniMental State Examination >20;

Exclusion criteria

Exclusion Criteria:

  • Unable to understand the aim of the study or unable to sign the informed consent form;
  • Subjects following a steroidal drug therapy or assuming drugs affecting cardiac function;
  • Subjects with psychiatric disorders;
  • Subjects with cardiovascular diseases for whom aerobic training is forbidden;
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Circuit Training

    Structured intervention to improve aerobic capacity, balance and strength

    Other: Circuit Training

  • Active comparator
    Usual Care

    Unstructured intervention to improve mobility and balance

    Other: Usual Care

Interventions

  • OtherCircuit Training

    20 minutes of High Intensity Aerobic Training (HI) on treadmill: 2 minutes warm up + 4x 4 minutes HI+ 2 minutes of active recovery; 10 minutes of dynamic balance training; 10 minutes of functional strength training.

  • OtherUsual Care

    Exercises aimed at improving mobility and balance

06

What researchers measure

Primary outcomes

  1. Change from Baseline Modified Fatigue Impact Scale at 6-8 weeks

    Provides an assessment of the effects of fatigue in terms of physical, cognitive and psychosocial functioning. Participant rates on a 5 point Likert scale (from 0="never" to 4= "Almost Always") their agreement with 21 statements. Higher numbers indicate greater fatigue.

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

Secondary outcomes

  1. Change from Baseline Modified Dynamic Gait Index at 6-8 weeks

    Assesses individual's ability to modify balance while walking during 8 specific tasks. Scoring system for each task is based on 3 aspects of walking performance: time to complete (min 0, max 3 points), gait pattern (min 0, max 3 points) and level of assistance (min 0, max 2 points). Total score ranges from 0 to 64 with greater scores indicating better performance.

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

  2. Change from Baseline 6 Minutes Walking Test at 6-8 weeks

    Assesses distance walked over 6 minutes as a sub-maximal test of endurance capacity.

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

  3. Change from Baseline 10 Meter Walking Test at 6-8 weeks

    Assesses walking speed over a short distance

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

  4. Change from Baseline 5-Time-Sit-To-Stand at 6-8 weeks

    Is used to quantify functional lower limb strength. Time taken to stand up and sit down for 5 consecutive times.

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

  5. Change from Baseline 12 item Multiple Sclerosis Walking Scale at 6-8 weeks

    Is a self report measure of the impact of MS on walking ability. The scoring gives a 1 (no limitation) to 5 (extreme limitation) option for each item.

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

  6. Change from Baseline Hospital Anxiety and Depression Scale at 6-8 weeks

    A two dimension scale to identify depression and anxiety. 14 items divided inti two 7 items subscales. The respondent rates each item on a 4 point scale (ranging from 0 to 3).Higher scores indicates greater anxiety and/or depression.

    Time frame: Baseline and at 6-8 weeks (after the completion of 16 training sessions)

07

Study locations

1 site
  • Fondazione Don Carlo Gnocchi Onlus
    Milan, 20148, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04006613
Lead sponsor
Fondazione Don Carlo Gnocchi Onlus
Responsible party
Sponsor
First posted
Jul 5, 2019
Start date
Feb 26, 2019
Primary completion
May 1, 2025
Completion
May 1, 2025
Last update
Jul 8, 2025

Study contacts

Davide Cattaneo, PhD
study director · IRCCS Fondazione Don Carlo Gnocchi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion